IPHA · Healthcare · $151M
$1.61+0.63%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
12/'26
6/'26 vs prev quarter
Quarterly Revenue Growth
“이번 분기 핵심 변화는 Sobi와의 lacutamab 협력이 완료되며 TELLOMAK-3 3상에 들어간 점이에요.”
In the company's words · 2026 2분기 earnings call